INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Compounding laws and requirements in Mississippi. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Permit Office-Use Compounding | permit office-use | Miss. Bd. of Pharmacy Regulations (wholesale-distribution exemptions; compounding Article)“The sale/purchase of a prescription drug or device by a 503a pharmacy to a licensed practitioner for office use, if the total annual dollar volume of these sales/purchases does not exceed five percent (5%) of that pharmacy's total annual prescription sales.” | Link | 2026-10-09 | high |
| Require Out-of-State Pharmacy Licenses for Compounding | require license | Miss. Bd. of Pharmacy Regulations, pharmacy permit classifications (D. Nonresident Pharmacy)“A Nonresident Pharmacy shall mean any pharmacy that is located outside the State of Mississippi which ships, mails or delivers prescription or legend drugs or devices to patients residing in this state.” | Link | 2026-10-09 | high |
| Require State 503B Outsourcing Facility Registration | require 503B | Miss. Bd. of Pharmacy Regulations, permit classification F (Sterile Product Outsourcing)“Sterile Product Outsourcing shall mean the compounding and distribution of sterile medications both in-state and out-of-state in accordance with FDA guidelines. The facility must apply for a Human Drug Compounding Outsourcing Registration from the U. S. Food and Drug Administration”Note: Stored false. Board issues a Sterile Product Outsourcing permit (application, fee, PIC certification). | Link | 2026-10-09 | high |
| Limit Anticipatory Compounding | Permitted based on routine, regularly observed prescribing patterns; compounding inordinate amounts without any historical basis is manufacturing. | Miss. Bd. of Pharmacy Regulations, compounding Article (1)(B),(G)“The compounding of inordinate amounts of drugs in anticipation of receiving prescriptions without any historical basis or the distribution of inordinate amounts of compounded products without a patient/practitioner/pharmacist relationship is considered manufacturing.” | Link | 2026-10-09 | high |
View full Mississippi profile (all layers) · Report an error on this page